These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21186232

  • 21. Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.
    Talatinian A, Chow SL, Heywood JT.
    Pharmacotherapy; 2012 Sep; 32(9):827-37. PubMed ID: 22949142
    [Abstract] [Full Text] [Related]

  • 22. Aldosterone blockade after myocardial infarction.
    Hackam DG.
    CMAJ; 2003 Sep 02; 169(5):444. PubMed ID: 12952808
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Aldosterone antagonists for all patients with heart failure?].
    Bauersachs J.
    MMW Fortschr Med; 2009 Apr 09; 151(15):33-5. PubMed ID: 19728679
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).
    Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M, Connolly SJ.
    Circulation; 2010 Dec 21; 122(25):2645-52. PubMed ID: 21135366
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Aldosterone and aldosterone antagonists. Eplerenone in cardiac insufficiency after myocardial infarction].
    Heinzl S.
    Med Monatsschr Pharm; 2005 Mar 21; 28(3):76-9. PubMed ID: 15794365
    [No Abstract] [Full Text] [Related]

  • 29. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B, Mazurek M, Lenarczyk R, Kowalski O, Kowalczyk J, Kalarus Z.
    Future Cardiol; 2010 May 21; 6(3):315-23. PubMed ID: 20462338
    [Abstract] [Full Text] [Related]

  • 30. Sudden cardiac death in postmyocardial-infarction patients.
    Fahed J, Floyd KC, Tighe DA.
    Panminerva Med; 2015 Jun 21; 57(2):71-86. PubMed ID: 25669163
    [Abstract] [Full Text] [Related]

  • 31. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ, MADIT-II Research Group.
    J Cardiovasc Electrophysiol; 2007 Aug 21; 18(8):833-8. PubMed ID: 17537209
    [Abstract] [Full Text] [Related]

  • 32. [Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study].
    Watanabe J.
    Nihon Rinsho; 2007 Apr 28; 65 Suppl 4():543-6. PubMed ID: 17508588
    [No Abstract] [Full Text] [Related]

  • 33. Is there new hope for sudden cardiac death prevention early after myocardial infarction?
    Stecker EC.
    Heart Rhythm; 2010 Nov 28; 7(11):1598-9. PubMed ID: 20727422
    [No Abstract] [Full Text] [Related]

  • 34. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 35. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
    Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD.
    Circulation; 2011 Jun 14; 123(23):2674-80. PubMed ID: 21606398
    [Abstract] [Full Text] [Related]

  • 36. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK.
    Cardiol Clin; 2014 May 14; 32(2):253-70. PubMed ID: 24793801
    [Abstract] [Full Text] [Related]

  • 37. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I, Multicenter Automatic Defibrillator Implantation Trial-II Investigators.
    Am J Cardiol; 2010 Mar 01; 105(5):581-6. PubMed ID: 20185000
    [Abstract] [Full Text] [Related]

  • 38. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE, Marwick TH, Krum H.
    Cardiovasc Revasc Med; 2006 Mar 01; 7(4):234-6. PubMed ID: 17174870
    [Abstract] [Full Text] [Related]

  • 39. Aldosterone antagonists--last man standing?
    Armstrong PW.
    N Engl J Med; 2011 Jan 06; 364(1):79-80. PubMed ID: 21073364
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.